Colgate-Palmolive (NYSE:CL) Shares Bought by Atlantic Trust Group LLC

Atlantic Trust Group LLC grew its stake in Colgate-Palmolive (NYSE:CL) by 3.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,232,500 shares of the company’s stock after purchasing an additional 41,709 shares during the quarter. Atlantic Trust Group LLC owned approximately 0.14% of Colgate-Palmolive worth $89,787,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Blue Chip Partners Inc. increased its stake in shares of Colgate-Palmolive by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 1,813 shares of the company’s stock valued at $134,000 after purchasing an additional 8 shares during the period. AlphaMark Advisors LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. Weatherstone Capital Management increased its stake in shares of Colgate-Palmolive by 0.7% in the second quarter. Weatherstone Capital Management now owns 4,069 shares of the company’s stock valued at $302,000 after purchasing an additional 28 shares during the period. Dorsey & Whitney Trust CO LLC increased its stake in shares of Colgate-Palmolive by 0.6% in the second quarter. Dorsey & Whitney Trust CO LLC now owns 5,642 shares of the company’s stock valued at $419,000 after purchasing an additional 34 shares during the period. Finally, Jackson Grant Investment Advisers Inc. increased its stake in shares of Colgate-Palmolive by 0.5% in the second quarter. Jackson Grant Investment Advisers Inc. now owns 7,028 shares of the company’s stock valued at $521,000 after purchasing an additional 35 shares during the period. Hedge funds and other institutional investors own 72.85% of the company’s stock.

In other Colgate-Palmolive news, VP Henning I. Jakobsen sold 36,215 shares of the stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $71.22, for a total value of $2,579,232.30. Following the completion of the sale, the vice president now owns 70,783 shares in the company, valued at approximately $5,041,165.26. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Jennifer Daniels sold 902 shares of the stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $75.82, for a total transaction of $68,389.64. Following the completion of the sale, the insider now owns 37,788 shares of the company’s stock, valued at approximately $2,865,086.16. The disclosure for this sale can be found here. Insiders sold a total of 414,019 shares of company stock valued at $29,541,377 in the last ninety days. Company insiders own 1.02% of the company’s stock.

Shares of Colgate-Palmolive (NYSE CL) traded down $0.68 during trading hours on Wednesday, reaching $69.62. 3,579,222 shares of the company were exchanged, compared to its average volume of 4,417,115. Colgate-Palmolive has a 1 year low of $67.52 and a 1 year high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42. The company has a market capitalization of $61,460.00, a PE ratio of 30.54, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.75 EPS for the quarter, hitting analysts’ consensus estimates of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The firm had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same quarter last year, the business posted $0.75 EPS. The company’s revenue was up 4.6% on a year-over-year basis. research analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date is Monday, January 22nd. Colgate-Palmolive’s dividend payout ratio is 70.18%.

Several equities research analysts have commented on CL shares. Citigroup dropped their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price objective for the company in a report on Monday, October 23rd. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a report on Saturday, November 25th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price objective for the company in a report on Tuesday, December 19th. Finally, Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a report on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price objective for the company. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $77.71.

ILLEGAL ACTIVITY WARNING: This piece of content was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/14/colgate-palmolive-cl-shares-bought-by-atlantic-trust-group-llc-3.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply